A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

Clinical trial NCT05857215 · COMPLETED

Trial details

NCT number: NCT05857215
Sponsor: Galmed Pharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Disease

Start date: 2021-03-05
Primary completion: 2021-07-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.